New hope for kids with severe bowel disease: drug trial launches
NCT ID NCT07158242
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tests a new medicine called afimkibart in children aged 2 to 17 with moderate to severe ulcerative colitis, a condition causing inflammation and sores in the colon. The goal is to see if the drug can safely reduce symptoms and help children reach remission (feeling better with less inflammation). About 100 children will take part, and the study lasts up to 52 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrooke's Hospital
RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Birmingham Children's Hospital
RECRUITINGBirmingham, B4 6NH, United Kingdom
-
Children's Healthcare of Atlanta
RECRUITINGAtlanta, Georgia, 30342, United States
-
Children's Hospital ZheJiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310052, China
-
Chulalongkorn University
RECRUITINGBangkok, 10330, Thailand
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
National Taiwan University Hospital
RECRUITINGTaipei, 100, Taiwan
-
Perth Children's Hospital
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Ramathibodi Hospital
RECRUITINGBangkok, Thailand
-
Royal Children's Hospital
RECRUITINGParkville, Victoria, 3052, Australia
-
Sheffield Childrens Hospital
RECRUITINGSheffield, S10 2TH, United Kingdom
-
Siriraj Hospital
RECRUITINGBangkok, 10700, Thailand
Conditions
Explore the condition pages connected to this study.